title: Leptin in human physiology and pathophysiology.
abstract: Leptin, discovered through positional cloning 15 years ago, is an adipocyte-secreted hormone with pleiotropic effects in the physiology and pathophysiology of energy homeostasis, endocrinology, and metabolism. Studies in vitro and in animal models highlight the potential for leptin to regulate a number of physiological functions. Available evidence from human studies indicates that leptin has a mainly permissive role, with leptin administration being effective in states of leptin deficiency, less effective in states of leptin adequacy, and largely ineffective in states of leptin excess. Results from interventional studies in humans demonstrate that leptin administration in subjects with congenital complete leptin deficiency or subjects with partial leptin deficiency (subjects with lipoatrophy, congenital or related to HIV infection, and women with hypothalamic amenorrhea) reverses the energy homeostasis and neuroendocrine and metabolic abnormalities associated with these conditions. More specifically, in women with hypothalamic amenorrhea, leptin helps restore abnormalities in hypothalamic-pituitary-peripheral axes including the gonadal, thyroid, growth hormone, and to a lesser extent adrenal axes. Furthermore, leptin results in resumption of menses in the majority of these subjects and, in the long term, may increase bone mineral content and density, especially at the lumbar spine. In patients with congenital or HIV-related lipoatrophy, leptin treatment is also associated with improvements in insulin sensitivity and lipid profile, concomitant with reduced visceral and ectopic fat deposition. In contrast, leptin's effects are largely absent in the obese hyperleptinemic state, probably due to leptin resistance or tolerance. Hence, another emerging area of research pertains to the discovery and/or usefulness of leptin sensitizers. Results from ongoing studies are expected to further increase our understanding of the role of leptin and the potential clinical applications of leptin or its analogs in human therapeutics.
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. cmantzor@bidmc.harvard.edu
authors.forename: Christos S
authors.initials: CS
authors.lastname: Mantzoros
authors.forename: Faidon
authors.initials: F
authors.lastname: Magkos
authors.forename: Mary
authors.initials: M
authors.lastname: Brinkoetter
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Sienkiewicz
authors.forename: Tina A
authors.initials: TA
authors.lastname: Dardeno
authors.forename: Sang-Yong
authors.initials: SY
authors.lastname: Kim
authors.forename: Ole-Petter R
authors.initials: OP
authors.lastname: Hamnvik
authors.forename: Anastasia
authors.initials: A
authors.lastname: Koniaris
mesh_terms: D000273:Adipose Tissue / Q000502:physiology*; D000568:Amenorrhea / Q000503:physiopathology; D004734:Energy Metabolism / Q000502:physiology; D005260:Female; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007027:Hypothalamic Diseases / Q000503:physiopathology; D007031:Hypothalamus / Q000502:physiology*; D020738:Leptin / Q000502:physiology*; D008297:Male; D009490:Neurosecretory Systems / Q000502:physiology; D012098:Reproduction / Q000502:physiology*
chemical_list: D020738:Leptin